| Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial A Grothey, E Van Cutsem, A Sobrero, S Siena, A Falcone, M Ychou, ... The Lancet 381 (9863), 303-312, 2013 | 3140 | 2013 |
| Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo … ME Pavel, JD Hainsworth, E Baudin, M Peeters, D Hörsch, RE Winkler, ... The Lancet 378 (9808), 2005-2012, 2011 | 1189 | 2011 |
| Red meat and colorectal cancer NF Aykan Oncology reviews 9 (1), 2015 | 282 | 2015 |
| Colorectal cancer in young patients: characteristics and outcome S Alici, NF Aykan, B Sakar, G Bulutlar, E Kaytan, E Topuz The Tohoku journal of experimental medicine 199 (2), 85-93, 2003 | 128 | 2003 |
| Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease F Tas, F Aykan, S Alici, E Kaytan, A Aydiner, E Topuz American journal of clinical oncology 24 (6), 547-550, 2001 | 126 | 2001 |
| Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors? DH Simsek, S Kuyumcu, C Turkmen, Y Sanlı, F Aykan, S Unal, I Adalet Journal of Nuclear Medicine 55 (11), 1811-1817, 2014 | 106 | 2014 |
| Timing of death from tumor recurrence after curative gastrectomy for gastric cancer B Sakar, H Karagol, M Gumus, M Basaran, E Kaytan, A Argon, Z Ustuner, ... American journal of clinical oncology 27 (2), 205-209, 2004 | 98 | 2004 |
| Objective response rate assessment in oncology: Current situation and future expectations NF Aykan, T Özatlı World Journal of Clinical Oncology 11 (2), 53, 2020 | 73 | 2020 |
| A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric … FD Içli F, Celik I, Aykan F, Uner A, Demirkazik A, Ozet A, Ozgüroğlu M, Taş ... Cancer 83 (12), 2475-2480, 1998 | 55* | 1998 |
| Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients T Salepci, H Yazici, F Dane, E Topuz, N Dalay, H Onat, F Aykan, M Seker, ... J BUON 14 (3), 495-9, 2009 | 54 | 2009 |
| Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer E Topuz, D Derin, G Can, E Kürklü, S Çınar, F Aykan, A Çevikbaş, R Dişçi, ... Investigational New Drugs 26, 567-572, 2008 | 51 | 2008 |
| Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial) NF Aykan, Ş Yalçın, NS Turhal, M Özdoğan, G Demir, M Özkan, A Yaren, ... Turkish Journal of Gastroenterology, 2015 | 47 | 2015 |
| Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis B Sakar, Z Ustuner, H Karagol, G Aksu, H Camlica, NF Aykan American journal of clinical oncology 27 (5), 489-493, 2004 | 36 | 2004 |
| Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma M Karabulut, M Gunaldi, H Alis, CU Afsar, S Karabulut, M Serilmez, ... Clinical and Translational Oncology 18, 160-171, 2016 | 31 | 2016 |
| Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study E Topuz, M Basaran, P Saip, A Aydiner, A Argon, B Sakar, F Tas, K Uygun, ... American journal of clinical oncology 25 (6), 619-624, 2002 | 31 | 2002 |
| Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer. SMT Thirion P, Piedbois P, Buyse M, O'Dwyer PJ, Cunningham D, Man A, Greco ... Br J Cancer 84 (5), 611-620, 2001 | 30* | 2001 |
| Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy N Faruk Aykan, I Yildiz, F Sen, L Kilic, S Keskin, R Ciftci, S Karabulut, ... Medical Oncology 30, 1-6, 2013 | 27 | 2013 |
| Bevacuzimab may be less effective in obese metastatic colorectal cancer patients M Artaç, L Korkmaz, HŞ Coşkun, F Dane, B Karabulut, M Karaağaç, ... Journal of gastrointestinal cancer 50, 214-220, 2019 | 23 | 2019 |
| The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival F Tas, NF Aykan, A Aydiner, K Uygun, M Basaran, H Camlica, E Topuz American journal of clinical oncology 23 (1), 53-57, 2000 | 22 | 2000 |
| Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer F Tas, NF Aykan, A Aydiner, V Yasasever, E Topuz American journal of clinical oncology 24 (2), 148-149, 2001 | 21 | 2001 |
Burak SakarOnkoloji Profesoru, Onkoloji Enstitusu, İstanbul Tip Fakultesi在 superonline.com 的电子邮件经过验证
